The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
Abstract Background Osteoporosis is a metabolic bone disease. Bisphosphonate (BP) and eldecalcitol (ELD) are two clinical first-line drugs for osteoporosis patients. However, the effect of ELD + BP vs. BP alone on osteoporosis treatment is still unclear. The present meta-analysis was conducted to ev...
Main Authors: | Zaoqian Zheng, Jinyu Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-020-01896-z |
Similar Items
-
Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
by: Zaoqian Zheng, et al.
Published: (2020-09-01) -
Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials
by: Xu Z, et al.
Published: (2016-01-01) -
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
by: Mizue Tanaka, et al.
Published: (2017-03-01) -
The Bisphosphonates versus Denosumab Efficiency in Postmenopausal Osteoporosis Treatment
by: Lorena Ciumărnean, et al.
Published: (2017-05-01) -
A postmenopausal osteoporotic woman losing bone mineral density despite bisphosphonates
by: Lai PSM, et al.
Published: (2013-10-01)